Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2013
DOI: 10.1002/mds.25410
|View full text |Cite
|
Sign up to set email alerts
|

Clinical features of neurodegeneration with brain iron accumulation due to a C19orf12 gene mutation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 7 publications
(13 reference statements)
0
6
1
Order By: Relevance
“…Hypointensity of the dorsal striatum has been reported in MPAN but not to the degree seen here (Dogu et al, 2013; Goldman et al, 2013; Hartig et al, 2013). Because the striatal-imaging characteristics are similar to those in the globus pallidus, we believe the striatal signal changes are due to iron deposition.…”
Section: Discussioncontrasting
confidence: 73%
“…Hypointensity of the dorsal striatum has been reported in MPAN but not to the degree seen here (Dogu et al, 2013; Goldman et al, 2013; Hartig et al, 2013). Because the striatal-imaging characteristics are similar to those in the globus pallidus, we believe the striatal signal changes are due to iron deposition.…”
Section: Discussioncontrasting
confidence: 73%
“…The recurrent mutation p.Gly69Arg [5,6,14] is supposed to disrupt the subcellular distribution of C19orf12 [2]. To our knowledge, only one other patient equally carrying this mutation in homozygous state has been described in the literature that showed a disease course comparable to our patient MPAN-3 (age of onset in the first decade, bilateral spasticity and optic atrophy -i.e.…”
Section: Discussionmentioning
confidence: 57%
“…MPAN-3 showed the homozygous recurrent mutation p.Gly69Arg [2,5,6,14]. She presented at age 10 with gait impairment and repeated falls due to spasticity of the lower limbs.…”
Section: C19orf12mentioning
confidence: 99%
“…Until now, 67 MPAN patients have been described in the literature (Deschauer et al, 2012;Dezfouli et al, 2013;Dogu et al, 2012;Goldman et al, 2013;Hartig et al, 2011;Hogarth et al, 2013;Panteghini et al, 2012;Schottmann, Stenzel, Lutzkendorf, Schuelke, & Knierim, 2013;Schulte et al, 2013). A compilation of all these cases shows that MPAN leads to a distinctive phenotype with prominent pyramidal and extrapyramidal signs, cognitive decline, neuropsychiatric abnormalities, optic atrophy, and motor axonal neuropathy (Table 3.1).…”
Section: Clinical Findingsmentioning
confidence: 99%
“…In addition to iron accumulation, generalized brain atrophy and/or cerebellar atrophy is found in a fraction of MPAN patients. Compilation of patients from references (Deschauer et al, 2012;Dezfouli et al, 2013;Dogu et al, 2012;Goldman et al, 2013;Hartig et al, 2011;Hogarth et al, 2013;Panteghini et al, 2012;Schottmann et al, 2013;Schulte et al, 2013).…”
Section: Neuroimagingmentioning
confidence: 99%